Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
05/2003
05/02/2003EP0881911B1 Immunogenic complex, iscom, for use in preparing a vaccine for juvenile individuals
05/02/2003EP0876397B1 Tumor rejection antigens presented by hla-b44 molecules, and uses thereof
05/02/2003EP0805628B1 Receptor specific transepithelial transport of immunogens
05/02/2003EP0802983B1 Expression of urokinase plasminogen activator inhibitors
05/02/2003EP0769964B1 Cck antibodies used to improve feed efficiency
05/02/2003EP0674710B1 Peptides with broad neoplastic specificity
05/02/2003EP0592521B1 Marrow-derived human mesenchymal stem cells and monoclonal antibodies specific for said cells
05/01/2003WO2003035848A1 Ibc-1 (invasive breast cancer-1), a putative oncogene amplified in breast cancer
05/01/2003WO2003035847A2 Il-13 mutein proteins, antibodies, compositions, methods and uses
05/01/2003WO2003035836A2 Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5' ends
05/01/2003WO2003035835A2 Glycoprotein compositions
05/01/2003WO2003035696A2 Humanized antibodies against icam-1, their production and uses
05/01/2003WO2003035694A2 Functional heavy chain antibodies, fragments thereof, library thereof and methods of production thereof
05/01/2003WO2003035687A1 Nogo receptor homologues and their use
05/01/2003WO2003035684A1 Ee3-protein family and corresponding dna sequences
05/01/2003WO2003035681A2 Mycobacterial genes down-regulated during latency
05/01/2003WO2003035680A1 Infectious salmon anaemia virus vaccine
05/01/2003WO2003035676A1 Groel chimeric protein and vaccine
05/01/2003WO2003035110A1 Treating vascular disease by inhibiting toll-like receptor-4
05/01/2003WO2003035106A1 Methods and compositions for inducing an immune response by co-administering a chemokine with an antigen
05/01/2003WO2003035105A2 A synthetic chimeric fusion protein with immuno-therapeutic uses
05/01/2003WO2003035104A2 Compositions and methods for selected tumor treatment
05/01/2003WO2003035100A1 Neuropilin as a novel therapeutic target for modulation of immune reponses
05/01/2003WO2003035077A1 N-substituted hydroxypyrimidinone carboxamide inhibitors of hiv integrase
05/01/2003WO2003035028A1 Modulating charge density to produce improvements in the characteristics of spray-dried proteins
05/01/2003WO2003035010A2 Thymosin augmentation of genetic immunization
05/01/2003WO2003035004A2 Immunotherapy for reversing immune suppression
05/01/2003WO2003035003A2 Fused cells, methods of forming same, and therapie utilizing same
05/01/2003WO2003034984A2 Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders
05/01/2003WO2003034981A2 Prevention of recurrent viral disease
05/01/2003WO2003034977A2 Combination therapy for treating disease
05/01/2003WO2003034903A2 Psma antibodies and protein multimers
05/01/2003WO2003034820A1 Th1 CELL ADOPTIVE IMMUNOTHERAPY
05/01/2003WO2003011223A3 Immunomodulatory compounds and methods of use thereof
05/01/2003WO2003008558A3 Cd4+cd25+ inhibitory hybridoma clones
05/01/2003WO2002100340A3 Improved vaccination against anthrax
05/01/2003WO2002100336A3 Tissue-specific endothelial membrane proteins
05/01/2003WO2002099055A3 Cips as modifiers of the p53 pathway and method of use
05/01/2003WO2002099046A3 Spo11 as modifier of the p53 pathway and methods of use
05/01/2003WO2002098897A3 Modified antibodies to prostate-specific membrane antigen and uses thereof
05/01/2003WO2002089615A3 Anti-ige antibody to treat ocular allergies
05/01/2003WO2002088183A3 G-protein coupled receptor
05/01/2003WO2002078741A3 Methods and compositions for modulating the immune system of animals
05/01/2003WO2002076391A3 Microbial feeds for aquaculture and agriculture
05/01/2003WO2002063007A3 TIMM8b-RELATED PROTEIN
05/01/2003WO2002062378A3 Hyperblebbing bacterial strains and use thereof for production of vaccines
05/01/2003WO2002045741A3 Helicobacter pylori prime and boost vaccination comprising caga and nap antigens
05/01/2003WO2002042460A3 Compositions and methods relating to colon specific genes and proteins
05/01/2003WO2002040513A9 Nucleic acid vaccine comprising a fusion protein including an adjuvant sequence from a plant viral coat protein
05/01/2003WO2002038600A3 C. elegans genes involved in viability and/or reproduction and uses thereof
05/01/2003WO2002026250A3 Vaccines for proliferative ileitis
05/01/2003WO2002022851A3 Novel tumor-associated marker
05/01/2003WO2002005146A3 Method for disigning protein libraries with altered immunogenicity
05/01/2003WO2001079291A3 Secreted proteins
05/01/2003WO2001066572A3 Polynucleotides isolated from e. coli of nature b2/d+ a-, and uses thereof
05/01/2003US20030083486 Physiologically active protein originating in mammals
05/01/2003US20030083472 Cell surface molecule mediating cell adhesion and signal transmission
05/01/2003US20030083466 cDNA clone MY1 that encodes a novel human 7-transmembrane receptor
05/01/2003US20030083465 Protein for use in treatment and prevention of angiogenesis
05/01/2003US20030083345 Method of treatment and/or prevention of brain, spinal or nerve injury
05/01/2003US20030083305 Modulating the immune response, reducing or inhibiting interferon expression; treating chronic inflammatory diseases and disorders, such as Crohn's disease, arthritis, Lyme disease, insulin-dependent diabetes, multiple sclerosis
05/01/2003US20030083298 Pharmaceutically active agents that impede the formation of amyloid by impeding the genesis or growth of DMS
05/01/2003US20030083291 Nucleotide vector, composition containing such vector, and vaccine for immunization against hepatitis
05/01/2003US20030083258 Modulation of leukocyte-endothelial interactions following ischemia
05/01/2003US20030083254 Heparanase-like proteins and nucleotides that encode them
05/01/2003US20030083253 Polynucleotide encoding autoantigens associated with endometriosis
05/01/2003US20030083235 Such as alpha-O-linked glycopeptides with clustered glycodomains which are useful as anticancer agents
05/01/2003US20030083229 Isolating T cells from mammal, incubating cells with protein expression product of activated oncogene or cancer-related gene associated with malignancy, detecting presence or absence of proliferation of T cells, determining malignancy
05/01/2003US20030082804 Peptide for use in the treatment of cell proliferation disorders
05/01/2003US20030082788 Recombinant infectious laryngotracheitis virus and uses thereof
05/01/2003US20030082785 24554, a human ubiquitin carboxyl-terminal hydrolase family member and uses therefor
05/01/2003US20030082781 Immunization of dairy cattle with GapC protein against Streptococcus infection
05/01/2003US20030082780 Nucleotide sequences coding polypeptide for use in the treatment of infections, pneumonia, toxic shock, brain and rheumatic diseases
05/01/2003US20030082747 Fusion polypeptides of human serum albumin and a therapeutically active polypeptide
05/01/2003US20030082740 Antitumor agent for use in the treatment of cancer
05/01/2003US20030082707 Membrane protein for use as tool in human therapeutics and diagnostics
05/01/2003US20030082680 Candida albicans gene, integrin-like protein, antibodies, and methods of use
05/01/2003US20030082672 Dna encoding galanin galr2 receptors and uses thereof
05/01/2003US20030082643 Human monoclonal antibodies to FC alpha receptor (CD89)
05/01/2003US20030082636 Antibody for use as tool in the treatment of blood disorders
05/01/2003US20030082628 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of cancer and nervous system disorders
05/01/2003US20030082627 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082620 Novel human genes and gene expression products: II
05/01/2003US20030082579 Generating library of preferential polypeptides; obtain nucleotide sequences, incubate with primers, amplify, recover amplification product, transform and express sequence incell, monitor and evaluate cell activity
05/01/2003US20030082554 Nucleotide sequences coding polypeptide for use in the treatment of immunlological, thyroid, metabolic, bone and pancreatic disorders
05/01/2003US20030082534 Nucleotide sequences coding polypeptide for use in diagnosis and treatment of brain and psychological disorders
05/01/2003US20030082533 Intelectin
05/01/2003US20030082526 Diagnosis and treatment of cancer
05/01/2003US20030082524 Isolation of peptide which immunologically mimics streptococci protein for use in vaccine development; prepare antibody sample, incubate with phage display library, detect bound phage, isolate and recover phage
05/01/2003US20030082523 Diagnosing viral infection in mammals; obtain fluid sample, extract nucleotide sequences, incubate with viral probe, detect hybridization, hybridization signal indicates presence of viral sequence
05/01/2003US20030082521 Polypeptide inducing antibodies neutralizing HIV
05/01/2003US20030082517 Treating viral disease in mammals; administer viricide to mammal, monitor activity of virus, reduced viral activity indicates effective viricide
05/01/2003US20030082234 Liquid composition of biodegradable block copolymer for drug delivery system and process for the preparation thereof
05/01/2003US20030082232 Adjust particle size; induce immunology response; vaccines
05/01/2003US20030082213 Use of microparticles combined with submicron oil-in-water emulsions
05/01/2003US20030082212 Desensitization therapy; reducing allergens sensitivity; administering prednison and antihistamines
05/01/2003US20030082211 Polysaccharide antigen in carrier
05/01/2003US20030082210 Sequence determination; calibration
05/01/2003US20030082209 Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines
05/01/2003US20030082205 Recombinant mva virus expressing dengue virus antigens, and the use thereof in vaccines
1 ... 1250 1251 1252 1253 1254 1255 1256 1257 1258 1259 1260 1261 1262 1263 1264 1265 1266 1267 1268 1269 1270 ... 1823